Pharmafile Logo

News and Press Releases

Anocca Raises SEK 440 Million to Advance Clinical Trial Targeting Pancreatic Cancer

Financing supports execution of early-stage clinical trials for Anocca’s lead programme VIDAR-1, powered by the Company’s leading-edge R&D platform, to target pancreatic cancer VIDAR-1 is the first non-viral gene-edited TCR-T...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: August 18, 2025

Anocca
info@anocca.com
Forskargatan 20C 151 36 Södertälje, Sweden

NXI Therapeutics Extends Pre-Seed Financing to ₣3.5M in Run-up to Larger Seed Financing

Kickfund joins group of investors including JFG Life Sciences Foundation, BaseLaunch and Venture Kick 18 June 2024 -- Basel, Switzerland -- NXI Therapeutics AG, developer of tomorrow’s disruptive immunotherapies by coronin...

Category: Biotechnology, Drug Discovery, Other
Posted: June 18, 2024

NXI Therapeutics
contact@nxitherapeutics.com
Spitalstrasse 41 4056 Basel, Switzerland

Barinthus Bio Names Experienced Physician, Leon Hooftman MD, as Chief Medical Officer 

Dr Hooftman brings more than 25 years’ experience in international drug development including immunology, autoimmunity, haematology, oncology and infectious diseases 1 May 2024 -- Oxford, UK -- Barinthus Biotherapeutics, formerly Vaccitech, a clinical-stage biopharmaceutical...

Category: BioManufacturing, Drug Discovery
Posted: May 1, 2024

Barinthus Biotherapeutics
Unit 6-10 Zeus Building Rutherford Avenue Harwell OX11 0DF